Galectin Therapeutics Inc. (GALT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$3.90−$0.0600 (−1.52%) on the dayAs of the close; data may be delayed.
GALT price, last 12 months
Key stats
- Previous close
- $3.96
- Open
- $3.93
- Day range
- $3.86 – $3.99
- 52-week range
- $2.03 – $7.13
- Volume
- 124.6K
- Avg volume (20 days)
- 335.6K
- Market cap
- $393.3M
Performance
1W+0.3%
1M−6.0%
3M−21.8%
6M+39.3%
YTD−6.3%
1Y−17.9%
vs S&P 500, 1Y−34.7 pts
Technicals and fundamentals
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $393.3M